Close

Wall Street slips, led by healthcare decline

Go back to Wall Street slips, led by healthcare decline

UBS Cuts Price Target on Procter & Gamble (PG) to $94 Following Analyst day

November 21, 2016 9:38 AM EST

UBS maintained a Buy rating on Procter & Gamble (NYSE: PG), and cut the price target to $94.00 (from $97.00), following the company's analyst day. In US Laundry, PG expects competition to continue/intensify, though it believes it will be focused on branding/innovation. Meanwhile, in... More

UBS Cuts Price Target on Abercrombie & Fitch (ANF) Following 3Q Miss

November 21, 2016 8:57 AM EST

UBS maintained a Neutral rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $15.00 (from $18.00), following the company's 3Q earnings report. ANF reported EPS of $0.02, significantly below the Street's $0.21 estimate. Flagship and tourist locations remain challenged at A&F, with international... More

FBR Capital Reiterates Underperform on Abercrombie & Fitch (ANF) Following 3Q

November 21, 2016 7:03 AM EST

FBR Capital reiterated an Underperform rating and $14.00 price target on Abercrombie & Fitch (NYSE: ANF) following the company 3Q earnings report. Net sales were down 6% over last year, and comps were down 6% for 3Q. Operating income for 3Q was $19.6M compared to $41M last year. Weakness in the U.S. was... More

Mizuho Securities Cuts Price Target on Abercrombie & Fitch (ANF) to $15

November 18, 2016 1:37 PM EST

Mizuho Securities maintained a Neutral rating on Abercrombie & Fitch (NYSE: ANF), and cut the price target to $15.00 (from $20.00), following the company's 3Q earnings report. 3Q EPS of $0.02 missed the Streets $0.20 estimate. Gross margin declined (130) bp due to FX, while lower AUC was... More

Jefferies Raises Price Target on Gap, Inc. (GPS) to $36 Following 3Q Report

November 18, 2016 9:00 AM EST

Jefferies reiterated a Buy rating on Gap, Inc. (NYSE: GPS), and raised the price target to $36.00 (from $32.00), following the company's 3Q earnings report. Management reiterated its FY'17 EPS guidance of $1.87-$1.92, implying 4Q EPS of $0.35-$0.40 (vs. consensus of $0.50).

Analyst Randal Konik... More